S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
OTCMKTS:RHHBY

Roche Stock Forecast, Price & News

$42.68
+0.92 (+2.20 %)
(As of 12/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$42.19
Now: $42.68▼
$42.68
50-Day Range
$39.99
MA: $41.90▼
$44.25
52-Week Range
$35.04
Now: $42.68▼
$47.15
Volume1.15 million shs
Average Volume1.79 million shs
Market Capitalization$292.29 billion
P/E Ratio16.80
Dividend Yield1.72%
Beta0.32
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. Further, the company discovers, develops, and delivers gene therapies. Roche Holding AG has collaboration with Gilead Sciences, Inc. for COVID-19. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.
Roche logo

Beat the Market (BTM) Rank™

Analyst Opinion: 2.4Community Rank: 2.4Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.96 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:RHHBY
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.roche.com
Phone41-61-688-1111
Employees97,735

Debt

Debt-to-Equity Ratio0.36
Current Ratio1.23
Quick Ratio0.93

Price-To-Earnings

Trailing P/E Ratio16.80
Forward P/E Ratio16.05
P/E Growth3.01

Sales & Book Value

Annual Sales$61.87 billion
Price / Sales4.72
Cash Flow$3.22 per share
Price / Cash Flow13.26
Book Value$5.27 per share
Price / Book8.10

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares6,848,490,000
Market Cap$292.29 billion
Next Earnings DateN/A
OptionableNot Optionable
$42.68
+0.92 (+2.20 %)
(As of 12/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RHHBY News and Ratings via Email

Sign-up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Roche (OTCMKTS:RHHBY) Frequently Asked Questions

How has Roche's stock been impacted by Coronavirus (COVID-19)?

Roche's stock was trading at $40.91 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, RHHBY shares have increased by 4.3% and is now trading at $42.68.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Roche?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche in the last year. There are currently 1 sell rating, 2 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Roche or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Roche?

Wall Street analysts have given Roche a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Roche wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for RHHBY?

14 brokers have issued 1-year price targets for Roche's shares. Their forecasts range from $48.00 to $48.00. On average, they expect Roche's stock price to reach $48.00 in the next twelve months. This suggests a possible upside of 12.5% from the stock's current price.
View analysts' price targets for Roche.

Are investors shorting Roche?

Roche saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 251,900 shares, a decline of 46.5% from the October 31st total of 471,000 shares. Based on an average daily trading volume, of 2,342,100 shares, the short-interest ratio is currently 0.1 days.
View Roche's Short Interest.

Who are some of Roche's key competitors?

Some companies that are related to Roche include Johnson & Johnson (JNJ), Pfizer (PFE), Novartis (NVS), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), AbbVie (ABBV), Novo Nordisk A/S (NVO), AstraZeneca (AZN), AstraZeneca (AZN), Bristol-Myers Squibb (BMY), Eli Lilly and (LLY), Sanofi (SNY), Sanofi (SNY), Commonwealth Bank of Australia (CSLLY) and GlaxoSmithKline (GSK).
View all competitors.

Who are Roche's key executives?

Roche's management team includes the following people:
  • Dr. Severin Schwan, CEO & Exec. Director (Age 53)
  • Dr. Alan Hippe, Chief Financial & IT Officer (Age 53)
  • Dr. Karl Mahler, Head of Investor Relations
  • Dr. Urs Jaisli, Chief Compliance Officer (Age 64)
  • Ms. Claudia Böckstiegel, Gen. Counsel (Age 56)
  • Ms. Cristina A. Wilbur, Chief People Officer (Age 53)
  • Mr. Nicolas Dunant, Head of Group Media Relations
  • Ehab Yousef, Head of Middle East Sub-Region 1
  • Mr. Boris L. Zaitra, Head of Group M&A (Age 48)
  • Lance Duan, Managing Director

What is Roche's stock symbol?

Roche trades on the OTCMKTS under the ticker symbol "RHHBY."

Who are Roche's major shareholders?

Roche's stock is owned by many different institutional and retail investors. Top institutional shareholders include Harding Loevner LP (0.09%), Schafer Cullen Capital Management Inc (0.02%), Bowen Hanes & Co. Inc. (0.02%), Douglass Winthrop Advisors LLC (0.02%), Riverbridge Partners LLC (0.01%) and Williams Jones Wealth Management LLC. (0.01%).

Which major investors are selling Roche stock?

RHHBY stock was sold by a variety of institutional investors in the last quarter, including Schafer Cullen Capital Management Inc, LSV Asset Management, New England Research & Management Inc., Chartwell Investment Partners LLC, Fairfield Bush & CO., Wendell David Associates Inc., Oxbow Advisors LLC, and Anderson Hoagland & Co..

Which major investors are buying Roche stock?

RHHBY stock was bought by a variety of institutional investors in the last quarter, including Harding Loevner LP, Douglass Winthrop Advisors LLC, Williams Jones Wealth Management LLC., Pacer Advisors Inc., Bowen Hanes & Co. Inc., Riverbridge Partners LLC, FCA Corp TX, and Kovack Advisors Inc..

How do I buy shares of Roche?

Shares of RHHBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Roche's stock price today?

One share of RHHBY stock can currently be purchased for approximately $42.68.

How big of a company is Roche?

Roche has a market capitalization of $292.29 billion and generates $61.87 billion in revenue each year. The company earns $13.58 billion in net income (profit) each year or $2.54 on an earnings per share basis. Roche employs 97,735 workers across the globe.

What is Roche's official website?

The official website for Roche is www.roche.com.

How can I contact Roche?

Roche's mailing address is GRENZACHERSTRASSE 124, BASEL V8, CH-4070. The company can be reached via phone at 41-61-688-1111 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.